National Bank of Canada
FHTX icon

National Bank of Canada’s Foghorn Therapeutics FHTX Stock Holding History

National Bank of Canada’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$952 Hold
200
– – ﹤0.01% 2678
2025
Q4 		$1.08K Buy
+200
New +$907 ﹤0.01% 2621

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

National Bank of Canada's FHTX Position: Q1 2026 in Review

National Bank of Canada held its Foghorn Therapeutics (FHTX) position steady in Q1 2026 at 200 shares worth $952. The position accounts for ﹤0.01% of the portfolio, ranked #2678.

National Bank of Canada first reported a position in FHTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.08K in Q4 2025. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • National Bank of Canada held 200 shares of Foghorn Therapeutics worth $952 as of Q1 2026.
  • National Bank of Canada left its Foghorn Therapeutics share count unchanged in Q1 2026.
  • Foghorn Therapeutics made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2678 holding.
  • National Bank of Canada first reported a position in Foghorn Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • National Bank of Canada's Foghorn Therapeutics position peaked at $1.08K in Q4 2025.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.